Related Experiment Video
Updated: Nov 4, 2025

09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.6K
Functions and Targets of miR-335 in Cancer
Lingling Ye1, Fen Wang1, Hao Wu1
1Department of Oncology, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Oncotargets and Therapy
|May 28, 2021
Summary
MicroRNAs (miRNAs) regulate genes and impact cancer. This review explores miR-335
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- MiRNAs can act as oncogenes or tumor suppressors in various cancers.
- miR-335 has garnered attention for its multifaceted roles in cancer biology.
Purpose of the Study:
- To review the diverse functions and targets of miR-335 across different cancer types.
- To elucidate the mechanisms by which miR-335 influences tumor initiation, progression, and metastasis.
- To assess the potential of miR-335 as a biomarker for cancer prognosis and treatment.
Main Methods:
- Literature review of studies on miR-335 in cancer.
- Analysis of miR-335 expression patterns in various malignancies.
- Examination of miR-335's regulatory roles and target interactions.
Main Results:
- miR-335 exhibits variable expression levels depending on cancer type.
- It can function as either an oncogene or a tumor suppressor.
- miR-335 impacts tumor microenvironment and drug sensitivity.
Conclusions:
- miR-335 is a key regulator in cancer, with potential as a prognostic biomarker.
- Understanding miR-335's functions is crucial for developing novel cancer therapies.
- Further research into miR-335 regulation and targets will enhance its clinical utility.
Related Concept Videos
MicroRNAs
3.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs
22.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.7K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
Cancer Stem Cells and Tumor Maintenance
5.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K

